Cargando…
Bioresorbable scaffolds in the treatment of coronary artery disease
Drug-eluting stents have reduced the risk of in-stent restenosis and have broadened the application in percutaneous coronary intervention in coronary artery disease. However, the concept of using a permanent metallic endovascular device to restore the patency of a stenotic artery has inherited pitfa...
Autores principales: | Zhang, Yaojun, Bourantas, Christos V, Farooq, Vasim, Muramatsu, Takashi, Diletti, Roberto, Onuma, Yoshinobu, Garcia-Garcia, Hector M, Serruys, Patrick W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3647349/ https://www.ncbi.nlm.nih.gov/pubmed/23662091 http://dx.doi.org/10.2147/MDER.S22547 |
Ejemplares similares
-
Bioresorbable Scaffolds: Current Evidence and Ongoing Clinical Trials
por: Bourantas, Christos V., et al.
Publicado: (2012) -
Bioresorbable scaffolds: a new paradigm in percutaneous coronary intervention
por: Tenekecioglu, Erhan, et al.
Publicado: (2016) -
Assessment of plaque evolution in coronary bifurcations located beyond everolimus eluting scaffolds: serial intravascular ultrasound virtual histology study
por: Lee, Il Soo, et al.
Publicado: (2013) -
Bioresorbable Drug-Eluting Magnesium-Alloy Scaffold for Treatment of Coronary Artery Disease
por: Campos, Carlos M., et al.
Publicado: (2013) -
Sealing of calcified plaques after bioresorbable scaffold implantations: a five-year follow up
por: Tenekecioglu, Erhan, et al.
Publicado: (2016)